Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

CUSIP: 92337R101

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+615,871
SEC-reported price per share
$32.29
Number of holders
45
Value change
+$18,991,919
Number of buys
26
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
71,530,793

Security key

92337R101

Report period

Q3 2026

Institutions

45

Top holders

10

Ownership snapshot

Top reported holders of VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
11/15
Latest evidence
30 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 8.9% 4 rows are not safely comparable across share classes. 13D/G row: Avoro Capital Advisors LLC Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 8.9%.

11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership Top 5
Avoro Capital Advisors LLC 8.9%
PRICE T ROWE ASSOCIATES INC /MD/ 7.7%
BlackRock, Inc. 7.4%
STATE STREET CORP 5.8%
Deep Track Capital, LP 5.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Avoro Capital Advisors LLC
13F 13D/G
Company
8.9%
Reported 13D/G · 31 Dec 2024
$245,612,034
5,723,888 shares
— 30 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
7.7%
Reported 13D/G · 31 Dec 2025
$276,595,072
5,461,988 shares
+$90,918,550 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.4%
Reported 13D/G · 30 Jun 2026
$246,636,382
5,747,760 shares
— 30 Jun 2026
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
5.8%
Reported 13D/G · 30 Jun 2026
$178,024,407
4,148,786 shares
— 30 Jun 2026
Deep Track Capital, LP
13D/G 13F
Company
5.5%
Reported 13D/G · 04 Mar 2026
$176,892,640
3,921,362 shares
$0 04 Mar 2026
James E. Flynn
13D/G
Deerfield Mgmt, L.P.
5.2%
Reported 13D/G · 06 Jun 2025
$75,299,151
3,348,117 shares
$0 06 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
45
Shares
4,214,381
Rows available
45
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
218
Q3 2026 holders
45
Holder diff
-173
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .